Medtronic raises dividend by 1.4%, continuing 49-year streak but lags peers Abbott and J&J.

Medtronic increased its quarterly dividend to $0.72 per share, marking a 1.4% raise and extending its dividend increase streak to 49 years. While this steady growth ensures a reliable 2.95% yield, it trails behind faster-growing peers like Abbott and Johnson & Johnson. The company’s strong cash flow and promising growth in cardiac ablation technology support dividend sustainability, though the recent spin-off of its diabetes unit and margin pressures pose risks. Investors should watch upcoming guidance updates and the impact of cardiac ablation growth on future dividend increases.

As of Oct 27, 2026 18:51 WIB, Medtronic (MDT) trades at USD 94.75 with a slight 0.04% decrease and offers a dividend yield of 3.04% on Pluang. This yield is higher than peers Abbott (ABT) and Johnson & Johnson (JNJ), which yield 2.4% and 2.01% respectively. Medtronic’s market cap stands at $121.25B, while investor activity on Pluang shows a full 100% buy interest in MDT shares. The notable dividend yield of 3.04% highlights Medtronic's appeal for income-focused investors despite the small price dip.